tradingkey.logo
tradingkey.logo

Encoded Therapeutics Announces FDA Alignment, Initiation Of Pivotal Study, And Asgct Presidential Symposium Presentation Of Etx101 In Dravet Syndrome

ReutersMar 25, 2026 12:29 PM
  • ENCODED THERAPEUTICS ANNOUNCES FDA ALIGNMENT, INITIATION OF PIVOTAL STUDY, AND ASGCT PRESIDENTIAL SYMPOSIUM PRESENTATION OF ETX101 IN DRAVET SYNDROME

Further company coverage: [ ]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI